683 Capital Management, LLC - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 41 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
683 Capital Management, LLC ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$7,150,770
-40.7%
699,000
-41.7%
0.53%
-47.7%
Q4 2022$12,049,950
+2.1%
1,199,0000.0%1.02%
+11.8%
Q3 2022$11,798,000
+1.1%
1,199,0000.0%0.91%
+10.7%
Q2 2022$11,672,000
-0.1%
1,199,0000.0%0.82%
+31.8%
Q1 2022$11,678,000
+0.7%
1,199,0000.0%0.62%
+46.4%
Q4 2021$11,597,000
-1.6%
1,199,0000.0%0.43%
-7.2%
Q3 2021$11,786,0001,199,0000.46%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q1 2022
NameSharesValueWeighting ↓
Arena Capital Advisors, LLC- CA 141,317$1,448,4992.02%
Atalaya Capital Management LP 500,000$5,115,0001.63%
MMCAP International Inc. SPC 800,000$8,184,0001.61%
ANGELO GORDON & CO., L.P. 300,000$3,069,0000.77%
FIR TREE CAPITAL MANAGEMENT LP 792,269$8,104,9120.64%
Castle Creek Arbitrage, LLC 530,000$5,421,9000.60%
683 Capital Management, LLC 699,000$7,150,7700.53%
GLAZER CAPITAL, LLC 850,590$8,7020.48%
P SCHOENFELD ASSET MANAGEMENT LP 500,000$5,125,0000.45%
METEORA CAPITAL, LLC 366,183$3,746,0520.44%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders